Tanaka Holdings (Japan)

Recent papers from Tanaka Holdings (Japan)

1. Clinical Characteristics and Novel Manometric Features of Pseudoachalasia: Identification of Loss of Respiratory Variation in Lower Esophageal Sphincter PressureJGH Open · 2026
2. Feasibility and Safety of Home Blood Transfusion for Children With Advanced Stage Cancer: Experiences From a Single InstitutePediatric Blood & Cancer · 2026
3. Safety and efficacy of a novel fecal microbiota transplantation method using hydrogen nanobubble water without antibiotics or bowel cleansing in children with autism spectrum disorder: an open-label, single-arm study demonstrating improvements in core and comorbidity symptomsFrontiers in Pediatrics · 2026
4. Increase in the prevalence of canine diabetes mellitus in Japan from 2015 to 2023: insights from insurance and clinical dataJournal of Veterinary Medical Science · 2025
5. Efficacy and safety of once-weekly somatrogon following up to 4 years of treatment in Japanese children with growth hormone deficiency: results from an open-label extension of a phase 3 studyEndocrine Journal · 2025
6. A case of disfluency in sentence-level speechJournal of allied health sciences · 2025
7. An example of dementia with speech characterized by pronounced sound stretchingJournal of allied health sciences · 2025
8. A Case of Ischemic Colitis Following Baloxavir Marboxil AdministrationInternal Medicine · 2025
9. Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitusFrontiers in Endocrinology · 2025
10. Incorporation of Metabolic Dysfunction‐Associated Steatotic Liver Disease in the Health Stage of Cardiovascular‐Kidney‐Metabolic Syndrome Improves Predictive Ability for Coronary Artery Disease in a Japanese General PopulationJournal of the American Heart Association · 2025
11. A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publicationTherapeutic Advances in Endocrinology and Metabolism · 2025
12. Mapping research trends in obsessive-compulsive disorder before and after the COVID-19 pandemic: a bibliometric analysis focusing on its molecular mechanismsFrontiers in Psychiatry · 2025
13. The Serum γ-Glutamyltransferase Level Is Associated with the Development of Hypertension in Alcohol Infrequent Drinkers but Not in Frequent DrinkersInternal Medicine · 2025
14. Can small dense LDL cholesterol be estimated from the lipid profile?Current Opinion in Lipidology · 2025
15. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease　― A 10-Year Cohort Study ―Circulation Reports · 2025
16. High Level of Estimated Small Dense Low-Density Lipoprotein Cholesterol as an Independent Risk Factor for the Development of Ischemic Heart Disease Regardless of Low-Density Lipoprotein Cholesterol Level　― A 10-Year Cohort Study ―Circulation Journal · 2025
17. Elevated urinary fatty acid-binding protein 4 level predicts future renal dysfunction and poor prognosis in Japanese patients with diabetes: a longitudinal cohort studyClinical Kidney Journal · 2025
18. Machine learning-based analyses of contributing factors for the development of hypertension: a comparative studyClinical and Experimental Hypertension · 2025
19. Onset of puberty in boys with short stature is earlier in those born small-for-gestational age and later in those born appropriate-for-gestational age than in the general healthy populationClinical Pediatric Endocrinology · 2025
20. Urinary fatty acid‐binding protein 4 is a promising biomarker for glomerular damage in patients with diabetes mellitusJournal of Diabetes Investigation · 2024